Too many Canadians live with multiple chronic conditions, say UBC researchers

December 10, 2019

A lack of physical activity, a poor diet and too much stress are taking their toll on the health of Canadians, says a new UBC study.

Researchers from UBC's Faculty of Medicine caution that too many Canadians live with a number of health issues that impact their ability to lead healthy lifestyles.

Brodie Sakakibara is an assistant professor with the Centre for Chronic Disease Prevention and Management based at UBC Okanagan. He, along with colleagues Adebimpe Obembe and Janice Eng from UBC's department of physical therapy, recently published a study examining how common it is for Canadians to have multiple--and serious--health conditions.

"Inactivity, poor diet and more than optimal amounts of stress combined with an aging population are resulting in increasing numbers of Canadians with cardiometabolic conditions, and thus increasing their risk of poor health," says Sakakibara.

Stroke, heart disease and diabetes are three of the most prevalent chronic diseases worldwide, he says and they have a substantial social and economic burden. They are cardiometabolic diseases--affecting the heart and blood vessels--mostly caused by lifestyle behaviours and are the leading causes of health resource use, hospitalizations, morbidity and mortality in Canada.

Cardiometabolic multimorbidity (CM) is having a diagnosis of at least two of those conditions. Using data from a 2016 Canadian Community Health Survey with 689,300 respondents, the researchers investigated CM and its connection to physical activity, diet and stress.

The study reports that the number of Canadians with CM or at risk of CM is high, and an increasing onset of cardiometabolic conditions is associated with higher chances of physical inactivity and stress.

"We found that people with all three diseases had four times the chance of reporting zero minutes of physical activity per week than people with none of the conditions. And similarly, they had four times the chance of reporting high levels of stress," says Sakakibara. "These lifestyle behaviours are clearly associated with bad or even dangerous health outcomes."

The issue, he adds, is that healthcare management for people with multiple chronic diseases is traditionally based on disease-specific strategies often independent of one another--a person with diabetes is treated for that chronic illness and not others. This leads to fragmented care with multiple care providers and systems.

"Often most patients with multiple chronic conditions develop complications that are clinically complex and become unique healthcare challenges. These complexities are often poorly understood, which means these patients have unmet health care needs," says Eng.

While getting more active, lowering stress and eating well won't cure all ailments, Sakakibara says it would certainly be a step in the right direction. The study suggests the time has come for greater efforts to prevent CM in individuals at high risk (i.e., those with one cardiometabolic condition), as well as efforts to help people with CM better manage their health and well-being.

"Lifestyle behaviour modification is an important strategy for the management and prevention of future heart or stroke events," he says. "Physical activity several times a week, combined with a healthier diet, can manage risk and complications, while at the same time helping to lower stress."
-end-
This study, partially funded by the Canadian Institutes of Health Research and Michael Smith Foundation, was published recently in BMC Public Health.

University of British Columbia Okanagan campus

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.